Online retailers and a Hong Kong pharmacy are offering slimming injections without prescriptions despite local authorities requiring a doctor’s approval before purchase, a Post investigation has found, with an expert warning it could lead to misuse. Weight-loss injections, which have been approved by Hong Kong authorities for use, have become increasingly popular around the world … Read more
Archyde Eli Lilly’s Oral Obesity Drug Shows Promise, Stock Surges april 18, 2025 Eli Lilly’s stock experienced a significant surge following the release of positive Phase 3 trial results for its experimental oral obesity drug, Orfoglipron. The data suggests a potential shift in how obesity and diabetes are treated, offering a convenient alternative to injectable … Read more
Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its blockbuster molecule tirzepatide. Now, with a pipeline chock-full of numerous incretin therapies, the Big Pharma’s new strategy will be to test some of those drugs across neurology and immunology indications. “A new focus area first in 2025 will be to … Read more